NEW DELHI: Russia’s approval of the antiviral drug Avifavir to treat COVID-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists. According to foreign media reports, Avifavir, described by its developers in Russia as perhaps the most promising anti Covid-19 drug in the world, is derived from Favipiravir, foreign media reported. Mumbai-based Glenmark Pharmaceuticals announced last week that Favipiravir is under phase 3 clinical trials - the penultimate stage in drug testing - in India. Stating that Avifavir has shown high efficacy in treating patients with coronavirus during clinical trials, the Russian Direct Investment Fund (RDIF) on Monday said it will deliver 60,000 courses of drug to Russian hospitals in June.
Khyber Pakhtunkhwa Chief Minister Ali Amin Gandapur. —Radio PakistanISLAMABAD. All the witnesses have been...
Former prime minister, MNA Raja Pervez Ashraf speaking on the occasion of World Press Freedom Day at the National...
Poster of “7th Sky Entertainment” drama serial “Khumar”. — YouTube/Geo News KARACHI: The last episode of...
Mahr Sahibzad Khan. — PMD websiteISLAMABAD: Prime Minister Shehbaz Sharif approved the summary for re-employment of...
Pashtunkhwa Mili Awami Party Chairman Mahmood Khan Achakzai is participating in a protest in Pishin against alleged...
In this screengrab, Agriculture Minister Ashiq Hussain Kirmani chairs a meeting, Punjab Agriculture Secretary Iftikhar...